112 related articles for article (PubMed ID: 19949849)
1. Blood pressure and risk of prostate cancer: Cohort Norway (CONOR).
Martin RM; Vatten L; Gunnell D; Romundstad P
Cancer Causes Control; 2010 Mar; 21(3):463-72. PubMed ID: 19949849
[TBL] [Abstract][Full Text] [Related]
2. Hypertension, heart rate, use of antihypertensives, and incident prostate cancer.
Fitzpatrick AL; Daling JR; Furberg CD; Kronmal RA; Weissfeld JL
Ann Epidemiol; 2001 Nov; 11(8):534-42. PubMed ID: 11709272
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive drugs and prostate cancer risk in a Finnish population-based cohort.
Siltari A; Murtola TJ; Talala K; Taari K; Tammela TLJ; Auvinen A
Scand J Urol; 2018; 52(5-6):321-327. PubMed ID: 30698056
[TBL] [Abstract][Full Text] [Related]
4. Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway.
Martin RM; Vatten L; Gunnell D; Romundstad P; Nilsen TI
Cancer Causes Control; 2009 Sep; 20(7):1181-92. PubMed ID: 19277881
[TBL] [Abstract][Full Text] [Related]
5. Lower urinary tract symptoms and risk of prostate cancer: the HUNT 2 Cohort, Norway.
Martin RM; Vatten L; Gunnell D; Romundstad P; Nilsen TI
Int J Cancer; 2008 Oct; 123(8):1924-8. PubMed ID: 18661522
[TBL] [Abstract][Full Text] [Related]
6. Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study).
Nilsen TI; Romundstad PR; Vatten LJ
Int J Cancer; 2006 Dec; 119(12):2943-7. PubMed ID: 17019717
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure changes during 22-year of follow-up in large general population - the HUNT Study, Norway.
Holmen J; Holmen TL; Tverdal A; Holmen OL; Sund ER; Midthjell K
BMC Cardiovasc Disord; 2016 May; 16():94. PubMed ID: 27176717
[TBL] [Abstract][Full Text] [Related]
8. Midlife metabolic factors and prostate cancer risk in later life.
Dickerman BA; Torfadottir JE; Valdimarsdottir UA; Wilson KM; Steingrimsdottir L; Aspelund T; Batista JL; Fall K; Giovannucci E; Sigurdardottir LG; Tryggvadottir L; Gudnason V; Markt SC; Mucci LA
Int J Cancer; 2018 Mar; 142(6):1166-1173. PubMed ID: 29114858
[TBL] [Abstract][Full Text] [Related]
9. Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.
Lu Y; Ness-Jensen E; Hveem K; Martling A
Am J Epidemiol; 2015 Nov; 182(10):883-93. PubMed ID: 26511906
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure and risk of cancer incidence and mortality in the Metabolic Syndrome and Cancer Project.
Stocks T; Van Hemelrijck M; Manjer J; Bjørge T; Ulmer H; Hallmans G; Lindkvist B; Selmer R; Nagel G; Tretli S; Concin H; Engeland A; Jonsson H; Stattin P
Hypertension; 2012 Apr; 59(4):802-10. PubMed ID: 22353615
[TBL] [Abstract][Full Text] [Related]
11. Baseline depressive symptoms are not associated with clinically important levels of incident hypertension during two years of follow-up: the multi-ethnic study of atherosclerosis.
Delaney JA; Oddson BE; Kramer H; Shea S; Psaty BM; McClelland RL
Hypertension; 2010 Feb; 55(2):408-14. PubMed ID: 20065156
[TBL] [Abstract][Full Text] [Related]
12. Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life.
Lee DS; Massaro JM; Wang TJ; Kannel WB; Benjamin EJ; Kenchaiah S; Levy D; D'Agostino RB; Vasan RS
Hypertension; 2007 Nov; 50(5):869-76. PubMed ID: 17893376
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of cruciferous vegetables and prostate cancer.
Giovannucci E; Rimm EB; Liu Y; Stampfer MJ; Willett WC
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1403-9. PubMed ID: 14693729
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular Risk and Atherosclerosis Progression in Hypertensive Persons Treated to Blood Pressure Targets.
Gronewold J; Kropp R; Lehmann N; Stang A; Mahabadi AA; Kälsch H; Weimar C; Dichgans M; Budde T; Moebus S; Jöckel KH; Erbel R; Hermann DM
Hypertension; 2019 Dec; 74(6):1436-1447. PubMed ID: 31679426
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort.
Stocks T; Hergens MP; Englund A; Ye W; Stattin P
Int J Cancer; 2010 Oct; 127(7):1660-8. PubMed ID: 20087861
[TBL] [Abstract][Full Text] [Related]
16. Cholesterol and prostate cancer risk: a long-term prospective cohort study.
Heir T; Falk RS; Robsahm TE; Sandvik L; Erikssen J; Tretli S
BMC Cancer; 2016 Aug; 16():643. PubMed ID: 27535659
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and esophageal and gastric cancer.
Lin Y; Ness-Jensen E; Hveem K; Lagergren J; Lu Y
Cancer Causes Control; 2015 Dec; 26(12):1825-34. PubMed ID: 26450604
[TBL] [Abstract][Full Text] [Related]
18. Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis.
Pai PY; Hsieh VC; Wang CB; Wu HC; Liang WM; Chang YJ; Wu TN
Int J Cardiol; 2015 Aug; 193():1-7. PubMed ID: 26002406
[TBL] [Abstract][Full Text] [Related]
19. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study.
Qiu C; Hu G; Kivipelto M; Laatikainen T; Antikainen R; Fratiglioni L; Jousilahti P; Tuomilehto J
Hypertension; 2011 Jun; 57(6):1094-100. PubMed ID: 21536985
[TBL] [Abstract][Full Text] [Related]
20. Socio-economic and lifestyle factors associated with the risk of prostate cancer.
Lund Nilsen TI; Johnsen R; Vatten LJ
Br J Cancer; 2000 Apr; 82(7):1358-63. PubMed ID: 10755415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
